Skip to main content
Premium Trial:

Request an Annual Quote

Doug Liu, Mark Gladwell, Laura Furmanski

Doug Liu is retiring from his role as senior vice president of global operations at Qiagen, CEO Peer Schatz said during an earnings call this week. He will be succeeded by Mark Gladwell, who joined the company from Alere, where he most recently served as senior vice president of global operations. 

In addition, Schatz said that Laura Furmanski, senior vice president of the bioinformatics business area, has resigned from the company. A search for her successor is in an advanced stage, Schatz said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.